Clinical Trial Update: Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab for pre-neoplastic high-grade HPV-related vulvar and cervical lesions; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Hpv-related Pre-neoplastic Lesions
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Cervical, Vaginal and Vulval Inflammatory Diseases | Phase 2 | Status: UNKNOWN